AI Analysis AI Analysis of EOLS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add EOLS to Watchlist?
Some Reasons Why To Add EOLS:
  • Strong return on equity of 174.9%
  • Consistently positive technical signals over the last month
  • High gross margin of 65.5%
PDF

Red day on Monday for Evolus Inc.
(Updated on Jul 13, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 10, 2026 Loss -1.36%

The Evolus Inc. stock price fell by -1.36% on the last day (Monday, 13th Jul 2026) from $6.61 to $6.52. During the last trading day the stock fluctuated 5.09% from a day low at $6.29 to a day high of $6.61. The price has fallen in 6 of the last 10 days and is down by -8.56% for this period. Volume has increased on the last day by 663 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $8.49 million.

The stock lies in the lower part of a wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $6.51 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 37.93% during the next 3 months and, with a 90% probability hold a price between $8.98 and $10.38 at the end of this 3-month period.

EOLS Signals & Forecast

There are few to no technical positive signals at the moment. The Evolus Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $6.80 and $6.66. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 25, 2026, and so far it has fallen -8.81%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Evolus Inc. stock

Evolus Inc. finds support from accumulated volume at $6.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.320 between high and low, or 5.09%. For the last week, the stock has had daily average volatility of 5.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EOLS) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Evolus Inc. to open at $6.47, and during the day (based on 14 day Average True Range), to move between $6.36 and $6.68, which gives a possible trading interval of +/-$0.328 (+/-5.16%) up or down from last closing price. If Evolus Inc. takes out the full calculated possible swing range there will be an estimated 5.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $6.57 (0.77%) than the support at $6.37 (2.30%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Evolus Inc. stock A Buy?

The Evolus Inc. stock holds several negative signals and despite the positive trend, we believe Evolus Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.535 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $6.47 ( 0.716%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

EOLS Performance

Trading levels for EOLS

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 6.79 4.19%
R2 6.67 2.32%
R1 6.60 1.16%
Price 6.52
S1 6.35 -2.59%
S2 6.28 -3.75%
S3 6.15 -5.62%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.13 9.36%
R2 6.74 3.37%
R1 6.57 0.767%
Price 6.52
S1 6.37 -2.30%
S2 6.32 -3.07%
S3 5.58 -14.42%

FAQ

What is the symbol for Evolus Inc. Stock and on which exchange is it traded?
The symbol for Evolus Inc. is EOLS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Evolus Inc. Stock?
The Evolus Inc. stock holds several negative signals and despite the positive trend, we believe Evolus Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Evolus Inc. Stock?
Evolus Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Evolus Inc. Stock.

What's the current price of Evolus Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an Evolus Inc. (EOLS) share was $6.52.

What is the 52-week high and low for Evolus Inc. Stock?
The 52-week high for Evolus Inc. Stock is $10.19 and the 52-week low is $3.86.

What is the market capitalization of Evolus Inc. Stock?
As of the Jul 13, 2026, the market capitalization of Evolus Inc. is 429.373M.

When is the next earnings date for Evolus Inc.?
The upcoming earnings date for Evolus Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT EVOLUS INC.
Evolus
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California....
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE